Red Cell Filter Sales

Red Cell Filter Sales Market Outlook

The global red cell filter sales market is projected to reach approximately USD 1.5 billion by 2035, with a compound annual growth rate (CAGR) of around 5.3% during the forecast period from 2025 to 2035. Growth in this market is driven by the rising prevalence of blood-related disorders that necessitate effective blood transfusion practices, which is further supported by increasing surgical procedures globally. The aging population, which is more susceptible to conditions requiring blood transfusions, coupled with advancements in medical technologies, significantly enhances the demand for red cell filters, ensuring high standards of patient safety and effective blood management. Furthermore, the expanding healthcare infrastructure and the growing awareness of the importance of blood filtration in transfusion therapy are expected to create new opportunities for market players. Additionally, the prevalence of infectious diseases continues to drive the need for stringent blood safety measures, consequently fueling the need for red cell filter sales.

Growth Factor of the Market

Several key growth factors are propelling the red cell filter sales market forward. Firstly, the increasing incidence of blood transfusions due to various medical conditions such as anemia, trauma, and cancer treatments is driving demand for effective blood filtration solutions. Secondly, advancements in filtration technology that enhance the effectiveness and safety of transfusions are attracting attention from healthcare providers and hospitals. Furthermore, the rising awareness regarding blood safety and infection control among healthcare professionals and patients stimulates market growth. The expansion of healthcare facilities, particularly in developing regions, is also contributing to the growth of this market as hospitals seek to improve their blood management systems. Additionally, government initiatives aimed at improving healthcare infrastructure and increasing funding for blood banks and hospitals will likely bolster the adoption of red cell filters in various medical applications.

Key Highlights of the Market

• Growing prevalence of blood transfusions and related medical conditions.
• Technological advancements in blood filtration systems.
• Increased awareness about blood safety and infection control measures.
• Expansion of healthcare facilities in emerging economies.
• Government initiatives contributing to improved healthcare infrastructure.

By Product Type

Single-Use Red Cell Filters:

Single-use red cell filters are increasingly popular due to their convenience and effectiveness in preventing the transfusion of contaminated blood products. These filters are designed to be used once and then discarded, ensuring that each patient receives blood that is free from particulate matter and leukocytes. The growing emphasis on patient safety and infection prevention in transfusion practices is a significant factor driving the demand for single-use filters. Additionally, their disposable nature minimizes the risk of cross-contamination and diseases transmission, making them a preferred choice in hospitals and blood banks where strict adherence to safety protocols is paramount. As the market continues to evolve, technological advancements are leading to the development of more efficient single-use filters that enhance the filtration process, further propelling their adoption.

Multiple-Use Red Cell Filters:

Multiple-use red cell filters serve as a cost-effective alternative for healthcare facilities that handle high volumes of blood transfusions. These filters are designed for repeated use, provided they are properly cleaned and maintained according to the manufacturer's guidelines. While they present a potential for cost savings, their adoption is often influenced by healthcare regulations and the need for stringent infection control practices. Facilities that prioritize sustainability and waste reduction may find these filters appealing as they help decrease the environmental impact associated with disposable options. However, the need for rigorous cleaning and sterilization processes can pose challenges in ensuring the safety of patients, thus making it critical for providers to weigh the benefits against the risk of contamination.

Pediatric Red Cell Filters:

Pediatric red cell filters are specifically designed for use in children and infants, addressing the unique physiological requirements of this demographic. These filters are essential in pediatric transfusion medicine, as children are particularly vulnerable to the complications associated with transfusions, such as transfusion-associated graft-versus-host disease (TA-GvHD). The development of filters that can effectively remove leukocytes and other contaminants without compromising the quality and efficacy of the blood product is driving their adoption in pediatric care settings. The growing number of pediatric surgical procedures, coupled with the increasing awareness of specialized care in transfusion practices, is presenting significant growth opportunities for this segment of the market.

Adult Red Cell Filters:

Adult red cell filters are widely used in general transfusion practices, aimed at ensuring the safety and effectiveness of blood transfusions in adults. With a focus on filtering out leukocytes, microaggregates, and other harmful particles, these filters play a crucial role in enhancing patient outcomes during surgeries and treatments that require blood transfusion. The rise in complex surgical procedures and the overall increase in blood transfusions in adult populations contribute to the robust demand for adult red cell filters. Continuous advancements in filtration technology are leading to the creation of more efficient and effective adult red cell filters, which in turn is expected to support market growth further.

Neonatal Red Cell Filters:

Neonatal red cell filters are developed to cater to the unique needs of newborns and infants, focusing on their delicate physiology and specific transfusion requirements. The use of these specialized filters is critical in preventing complications associated with blood transfusions in neonates, such as hyperbilirubinemia and other transfusion reactions. Neonatal patients require a heightened level of care, and the introduction of advanced filtration technology specifically designed for this demographic is essential for improving health outcomes. The increasing focus on maternal and child health, alongside the rise in neonatal surgeries and interventions that require blood transfusions, is significantly enhancing the demand for neonatal red cell filters in healthcare facilities.

By Application

Blood Transfusion:

Blood transfusion is a primary application for red cell filters, as they play a pivotal role in ensuring the safety and efficacy of transfused blood. These filters are essential in preventing transfusion-related complications by removing contaminants, such as leukocytes and microaggregates, from the blood products before they are administered to patients. The growing incidence of surgical procedures and medical conditions that necessitate blood transfusions is driving the demand for effective filtration systems. Additionally, healthcare facilities are increasingly prioritizing patient safety and infection control, further enhancing the use of red cell filters in blood transfusion practices. The advancement of filtration technologies that improve the efficiency and reliability of these filters is expected to propel this application segment significantly.

Apheresis:

Apheresis, a medical procedure used to collect specific blood components, is another key application for red cell filters. During apheresis, blood is drawn from the patient, filtered to separate the desired components, and then returned to the patient or stored for later use. Red cell filters are essential in this process to ensure that the collected blood components are free from harmful particulates and contaminants, thereby enhancing patient safety. The growing prevalence of blood disorders, such as sickle cell disease and various hematological malignancies, is driving the demand for apheresis procedures, which in turn boosts the need for high-quality red cell filters. As advancements in apheresis technology continue to evolve, the demand for specialized filtration products will likely increase correspondingly.

Cell Salvage:

Cell salvage is a process that involves the collection and reinfusion of a patient’s own blood lost during surgery, and red cell filters are crucial in this application to ensure the safety and efficacy of the salvaged blood. By filtering out contaminants and cellular debris, these filters help maintain the quality of the reinfused blood, reducing the risk of transfusion-related complications. The increasing number of surgical procedures, particularly in high-risk settings, is driving the growth of the cell salvage market, thereby enhancing the demand for effective red cell filtration solutions. Moreover, the trend towards minimally invasive surgical techniques, which often involve significant blood loss, is further contributing to the importance of cell salvage and the accompanying use of red cell filters.

By Distribution Channel

Hospitals:

Hospitals represent a primary distribution channel for red cell filters, as they are the main providers of transfusion services. The increasing number of surgical procedures and medical treatments that require blood transfusions in hospitals is a major factor driving the demand for red cell filters. Hospitals are increasingly prioritizing patient safety and infection control measures, leading to a higher adoption of effective filtration solutions. Furthermore, the trend towards improved blood management practices and the development of specialized transfusion protocols are enhancing the need for red cell filters in these facilities. Hospitals often work with suppliers to ensure they have access to the latest technologies and innovations in filtration to meet their specific needs.

Blood Banks:

Blood banks serve as a critical distribution channel for red cell filters, as they play a key role in the collection, processing, and storage of blood products. The demand for effective filtration solutions in blood banks is driven by the need to ensure the safety and quality of stored blood products. Blood banks are increasingly investing in advanced filtration technologies to meet regulatory standards and improve patient outcomes. As the importance of blood preservation and safety continues to grow, the reliance on high-quality red cell filters in blood banks is expected to increase. Furthermore, collaborations between blood banks and filter manufacturers are likely to foster innovation in filtration methods and technologies.

Specialty Clinics:

Specialty clinics, which focus on specific healthcare needs such as hematology and oncology, represent another essential distribution channel for red cell filters. These clinics often handle complex cases that require careful blood management and transfusion practices. The increasing prevalence of blood disorders and the rising demand for specialized care in these areas are driving the need for effective filtration solutions. Specialty clinics may utilize red cell filters tailored to their specific patient populations to ensure the highest standards of patient safety. As these clinics continue to expand and innovate in their treatment offerings, the demand for red cell filters is expected to grow correspondingly.

Online Platforms:

Online platforms are becoming an increasingly popular distribution channel for red cell filters, driven by the growing trend towards e-commerce in the healthcare sector. The convenience and accessibility of purchasing medical supplies online are appealing to healthcare providers, especially smaller facilities and clinics that may not have direct access to traditional supply chains. Online platforms provide a wide range of options for red cell filters, enabling healthcare providers to compare products and prices easily. Additionally, the availability of detailed product information and reviews on these platforms enhances purchasing decisions. The expansion of online distribution channels is likely to continue transforming the way healthcare providers procure red cell filters in the future.

Others:

Other distribution channels for red cell filters include pharmacies, medical supply stores, and direct sales from manufacturers. These channels cater to diverse customer needs and preferences, providing additional options for healthcare facilities and professionals. The demand for red cell filters through these channels is influenced by various factors, including regional market dynamics and healthcare practices. As the market becomes more competitive, manufacturers are likely to explore and utilize multiple distribution channels to reach a broader audience and enhance their market presence. The diversification of distribution channels is expected to drive growth in the red cell filter sales market as healthcare providers seek flexible and efficient procurement solutions.

By Material Type

PVC Red Cell Filters:

PVC (polyvinyl chloride) red cell filters are widely used due to their cost-effectiveness and versatility in various medical applications. PVC filters possess good chemical resistance and can be manufactured in different sizes and configurations, making them suitable for a range of filtration needs in blood transfusion practices. However, concerns about the leaching of harmful substances from PVC into blood products have led to a growing preference for alternative materials. Nevertheless, the use of PVC filters remains significant, particularly in facilities where cost considerations are paramount. Continuous advancements in PVC filter technology aim to enhance their safety and performance while addressing the concerns associated with their use.

Polycarbonate Red Cell Filters:

Polycarbonate red cell filters are known for their durability and high transparency, which allows for effective monitoring during blood filtration processes. The use of polycarbonate in filtration systems provides excellent filtration efficiency, making it suitable for applications that require stringent quality control. These filters are less prone to breakage compared to their PVC counterparts, which enhances their appeal in busy hospital environments. As safety and performance continue to be key priorities in blood transfusion practices, the demand for polycarbonate red cell filters is expected to grow. Innovations in polycarbonate filter designs are also likely to improve their functionality and further propel their adoption within the market.

Polypropylene Red Cell Filters:

Polypropylene red cell filters offer excellent chemical resistance and are often used in scenarios where other materials may fail. Their ability to withstand higher temperatures makes them suitable for sterilization processes, ensuring that they maintain their integrity and performance over time. The use of polypropylene in filtration systems is increasing due to its favorable characteristics, including low extractables and strong mechanical properties. As healthcare providers continue to prioritize safety and efficacy in blood transfusion practices, the demand for polypropylene filters is poised to rise. Furthermore, advancements in polypropylene filter technology are likely to enhance their effectiveness and broaden their applications in various medical settings.

Polyester Red Cell Filters:

Polyester red cell filters are characterized by their high filtration efficiency and capability to remove contaminants effectively. These filters are particularly valuable in applications requiring high-performance filtration, such as in blood transfusions and apheresis. The use of polyester fibers in filter media enhances the overall reliability of the filtration process, making them an attractive option for healthcare providers seeking to ensure patient safety. As the focus on blood management and infection control continues to intensify, the adoption of polyester red cell filters is expected to increase. Innovations in polyester filter technology may also lead to improved performance, further driving market growth.

Others:

Other material types used for red cell filters include various composite and specialty materials that combine the benefits of different polymers to enhance filtration performance. These filters are often designed for specific applications where traditional materials may not provide the desired level of filtration efficiency. The development of these alternative materials reflects the growing emphasis on innovation in blood filtration technologies and the need for customized solutions in medical settings. As healthcare providers seek more efficient and effective filtration options, the demand for filters made from alternative materials is likely to grow, contributing to the overall expansion of the red cell filter sales market.

By Region

The North American region is expected to dominate the red cell filter sales market due to the presence of advanced healthcare infrastructure and a high volume of surgical procedures requiring blood transfusions. The growing prevalence of blood-related disorders and the increasing emphasis on patient safety are driving the demand for red cell filters in this region. Furthermore, the regulatory environment in North America encourages the adoption of innovative filtration technologies, further bolstering market growth. The regional market is projected to witness a CAGR of approximately 5.5% during the forecast period, emphasizing the significant opportunities for stakeholders in North America.

In Europe, the red cell filter sales market is also experiencing substantial growth, driven by the rising awareness of blood safety and the implementation of stringent regulations governing blood transfusion practices. The increasing number of surgical procedures and the growing prevalence of blood-related disorders in the region are expected to further stimulate demand for red cell filters. Additionally, the expansion of healthcare facilities and advancements in medical technologies will contribute to the growth of this market. The European market is anticipated to maintain a steady CAGR of around 5.0% throughout the forecast period, indicating a robust outlook for industry players in this region.

Opportunities

The red cell filter sales market presents numerous opportunities, particularly in emerging economies where healthcare infrastructure is rapidly developing. As countries invest in improving their healthcare systems, there is an increasing need for high-quality blood filtration solutions, making it an opportune time for manufacturers to expand their presence in these markets. The growing population and rising incidence of blood-related conditions in these regions underscore the necessity for effective transfusion practices, driving demand for red cell filters. Moreover, collaborations with local hospitals and healthcare facilities can facilitate market entry and establish strong distribution networks, creating mutual benefits for manufacturers and healthcare providers alike.

Another significant opportunity lies in the ongoing advancements in filtration technologies, which are paving the way for the development of next-generation red cell filters. Innovations such as bioengineered materials and advanced filtration mechanisms aim to enhance the efficiency and safety of blood filtration processes. Manufacturers that invest in research and development to create cutting-edge products can gain a competitive edge and capture a larger market share. Additionally, the increasing focus on personalized medicine and tailored treatment approaches may drive the demand for specialized red cell filters, creating further avenues for growth and innovation in the market.

Threats

While the red cell filter sales market is poised for growth, several threats could impact its trajectory. One of the primary concerns is the increasing regulatory scrutiny surrounding medical devices and blood filtration products. Stricter regulations and compliance requirements can impose significant challenges for manufacturers, potentially delaying product approvals and market entry. Additionally, the evolving landscape of healthcare policies and reimbursement mechanisms may influence the adoption of red cell filters, as healthcare providers weigh costs against patient outcomes. Furthermore, the emergence of alternative blood management technologies may pose competitive threats to traditional filtration solutions, necessitating ongoing innovation and adaptation among industry players to maintain relevance.

Another critical threat to the red cell filter sales market is the risk of supply chain disruptions, which can arise from geopolitical factors, natural disasters, or global pandemics. As seen during the COVID-19 pandemic, disruptions in manufacturing and transportation can lead to significant shortages in medical supplies, including red cell filters. Such interruptions can adversely affect patient care and outcomes, prompting healthcare providers to seek alternative sources or solutions. Ensuring a resilient and diversified supply chain will be essential for manufacturers to mitigate these risks and maintain a steady supply of red cell filters in the market.

Competitor Outlook

• Terumo Corporation
• Fresenius Kabi AG
• Becton, Dickinson and Company
• Grifols S.A.
• Haemonetics Corporation
• Macopharma
• Medtronic plc
• HemoCue AB
• Blood Systems, Inc.
• JMS Co., Ltd.
• Sanofi S.A.
• Bio-Rad Laboratories, Inc.
• Charité – Universitätsmedizin Berlin
• Hematologic Technologies, Inc.
• Asahi Kasei Medical Co., Ltd.

The competitive landscape of the red cell filter sales market is characterized by the presence of several established players and emerging companies striving to enhance their market position. Major companies are increasingly focusing on innovation and technological advancements to develop cutting-edge filtration products that meet the evolving demands of healthcare providers. Strategic collaborations, mergers, and acquisitions among industry players are common as they seek to leverage synergies and expand their product portfolios. Furthermore, companies are investing in research and development to create specialized solutions for different application areas, thereby enhancing their competitive edge in the market.

Among the prominent players in the market, Terumo Corporation stands out with its diverse range of blood filtration products and a strong global presence. The company is committed to improving transfusion safety and has been at the forefront of developing advanced filtration technologies. Similarly, Fresenius Kabi AG is known for its extensive product offerings in blood management, with a focus on quality and patient safety. The company’s commitment to research and development has enabled it to remain competitive in the market, continuously enhancing its product offerings.

Grifols S.A. is another key player in the red cell filter sales market, recognized for its innovative approaches in blood health and transfusion safety. The company invests heavily in research to develop cutting-edge filtration technologies that address specific healthcare needs. Additionally, Haemonetics Corporation has established itself as a leader in blood management solutions, with a strong emphasis on quality and safety in its product development. The company’s comprehensive approach to blood filtration and management positions it well within the competitive landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 HemoCue AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Macopharma
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sanofi S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Grifols S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 JMS Co., Ltd.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Medtronic plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Blood Systems, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Haemonetics Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Kasei Medical Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Becton, Dickinson and Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hematologic Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Charité – Universitätsmedizin Berlin
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Red Cell Filter Sales Market, By Application
    • 6.1.1 Blood Transfusion
    • 6.1.2 Apheresis
    • 6.1.3 Cell Salvage
  • 6.2 Red Cell Filter Sales Market, By Product Type
    • 6.2.1 Single-Use Red Cell Filters
    • 6.2.2 Multiple-Use Red Cell Filters
    • 6.2.3 Pediatric Red Cell Filters
    • 6.2.4 Adult Red Cell Filters
    • 6.2.5 Neonatal Red Cell Filters
  • 6.3 Red Cell Filter Sales Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Blood Banks
    • 6.3.3 Specialty Clinics
    • 6.3.4 Online Platforms
    • 6.3.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Red Cell Filter Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Red Cell Filter Sales market is categorized based on

By Product Type

• Single-Use Red Cell Filters
• Multiple-Use Red Cell Filters
• Pediatric Red Cell Filters
• Adult Red Cell Filters
• Neonatal Red Cell Filters

By Application

• Blood Transfusion
• Apheresis
• Cell Salvage

By Distribution Channel

• Hospitals
• Blood Banks
• Specialty Clinics
• Online Platforms
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Terumo Corporation
• Fresenius Kabi AG
• Becton, Dickinson and Company
• Grifols S.A.
• Haemonetics Corporation
• Macopharma
• Medtronic plc
• HemoCue AB
• Blood Systems, Inc.
• JMS Co., Ltd.
• Sanofi S.A.
• Bio-Rad Laboratories, Inc.
• Charité – Universitätsmedizin Berlin
• Hematologic Technologies, Inc.
• Asahi Kasei Medical Co., Ltd.